Lipid-Laden Macrophages in Pulmonary Diseases.
Yin ZhuDooyoung ChoiPayaningal R SomanathDuo ZhangPublished in: Cells (2024)
Pulmonary surfactants play a crucial role in managing lung lipid metabolism, and dysregulation of this process is evident in various lung diseases. Alternations in lipid metabolism lead to pulmonary surfactant damage, resulting in hyperlipidemia in response to lung injury. Lung macrophages are responsible for recycling damaged lipid droplets to maintain lipid homeostasis. The inflammatory response triggered by external stimuli such as cigarette smoke, bleomycin, and bacteria can interfere with this process, resulting in the formation of lipid-laden macrophages (LLMs), also known as foamy macrophages. Recent studies have highlighted the potential significance of LLM formation in a range of pulmonary diseases. Furthermore, growing evidence suggests that LLMs are present in patients suffering from various pulmonary conditions. In this review, we summarize the essential metabolic and signaling pathways driving the LLM formation in chronic obstructive pulmonary disease, pulmonary fibrosis, tuberculosis, and acute lung injury.
Keyphrases
- pulmonary hypertension
- fatty acid
- pulmonary fibrosis
- inflammatory response
- end stage renal disease
- lipopolysaccharide induced
- ejection fraction
- chronic kidney disease
- mycobacterium tuberculosis
- lps induced
- newly diagnosed
- emergency department
- adipose tissue
- oxidative stress
- high fat diet
- peritoneal dialysis
- metabolic syndrome
- climate change
- human health
- epithelial mesenchymal transition
- patient reported outcomes
- hepatitis c virus
- electronic health record